MicroRNA-4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of TrkA

Xianglong Tan; Jinyong Lv; Guodong Zhao; Zhiming Zhao; Chenggang Li; Yong Xu; Minggen Hu

doi:10.1002/jgm.2938

MicroRNA-4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of TrkA

J Gene Med. 2017 Jan;19(1-2). doi: 10.1002/jgm.2938.

Authors

Xianglong Tan¹, Jinyong Lv², Guodong Zhao¹, Zhiming Zhao¹, Chenggang Li¹, Yong Xu¹, Minggen Hu¹

Affiliations

¹ Second Department of Surgical Oncology, People's Liberation Army General Hospital, Beijing, China.
² Department of Hepatobiliary, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, China.

PMID: 27936486
DOI: 10.1002/jgm.2938

Abstract

Background: In the present study, we investigated the expression profile and functional mechanism of microRNA-4656 in human pancreatic cancer (PC).

Methods: MiR-4656 expression in PC tumors was examined using a quantitative reverse transcriptase-polymerase chain reaction in 134 patients. Associations between tumorous miR-4656 expression and clinicopathological parameters of patients, as well as overall survival, were analyzed. MiR-4656 expression was also examined in PC in vitro cell lines. In Capan-1 and AsPC-1 PC cells, lentivirus-induced miR-4656 overexpression or downregulation was applied to investigate its functional regulations on PC in vitro proliferation and invasion, as well as in vivo transplant growth. The association of miR-4656 and its downstream target, the tropomyosin receptor kinase A (TrkA) gene, was investigated in both cell line and clinical pancreatic tumors. In miR-4656-overerxpressed PC cells, TrkA was overexpressed with the aim of investigating its role in miR-4656-induced functional regulation in PC.

Results: MiR-4656 was downregulated in PC. Low tumorous miR-4656 expression was associated with a poor prognosis and overall survival of patients. MiR-4656 was also found to be downregulated in PC cell lines. MiR-4656 overexpression in Capan-1 and AsPC-1 cells significantly inhibited cancer proliferation and invasion in vitro, as well as explant growth in vivo, whereas miR-4656 downregulation had no effect on cancer development. The TrkA gene was directly bound by miR-4656, and reversely expressed in PC tumors as miR-4656. TrkA overexpression reversed the inhibitory effect of miR-4656-overexpression on PC proliferation and invasion.

Conclusions: MiR-4656 is expressed to a low extent and is a potential biomarker in PC. Overexpressing miR-4656 has tumor suppressive effects on PC development both in vitro and in vivo, likely through its downstream target of the TrkA gene.

Keywords: TrkA; biomarker; invasion; miR-4656; overall survival; pancreatic cancer; proliferation; transplant.

Publication types

Retracted Publication